CACNA1A and spinocerebellar ataxia type 6: Furthermore, the potential suppression of the CACNA1A internal ribosomal entry site (IRES) function presents a novel therapeutic strategy for addressing disorders like spinocerebellar ataxia type 6 (SCA6), wherein the misregulation of α1ACT, a transcription factor, negatively impacts neuronal health [37].